GLP-1RA users had a 37% lower risk of developing dementia compared to those on other antidiabetic drugs. Stroke risk reduced ...

Glucagon-like peptide 1 receptor agonists may offer neuroprotective and survival benefits beyond blood sugar control.

Treatment options for patients with moderately to severely active Crohn's disease have expanded in the past decade, with ...

Pennington Biomedical researchers and their collaborators observed decreased activity in the brain regions responsible for ...

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

The game-changing weight loss jabs have ushered in a new era in the war on obesity, but have also been linked to other health benefits.

Recently, research results have been announced that GLP-1 (glucagon-like peptide) receptor agonist drugs have a positive ...

Key TakeawaysThe weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer. Tumor ...

Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type ...

In patients with obesity, tirzepatide improved cardiometabolic parameters and risk for cardiovascular disease, but the ...

Weight loss injections can help people lose more weight than with other methods of weight loss, including lifestyle changes ...

Hormone therapy as an adjunctive to tirzepatide was associated with greater weight loss than tirzepatide alone among postmenopausal women.